Revascularization of pancreatic islet allografts is enhanced by α-1-Antitrypsin under anti-inflammatory conditions

Cell Transplantation

Volumn 22, Issue 11, 2013, Pages 2119-2133

  Bellacen, Keren ^a   Kalay, Noa ^a   Ozeri, Eyal ^a   Shahaf, Galit ^a   Lewis, Eli C ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Angiogenesis; Diabetes; Inflammation; Transgenic; Transplantation

Indexed keywords

ALPHA 1 ANTITRYPSIN; CD31 ANTIGEN; MATRIGEL; SMOOTH MUSCLE ACTIN; VON WILLEBRAND FACTOR; ACTIN; ALPHA-SMOOTH MUSCLE ACTIN, MOUSE; COLLAGEN; DRUG COMBINATION; LAMININ; PROTEOGLYCAN; TRANSCRIPTOME; VASCULOTROPIN A;

ALLOGRAFT; ANGIOGENESIS; ANIMAL CELL; ARTICLE; ASSAY; CONTROLLED STUDY; EPITHELIUM CELL; EXPLANT; HUMAN; HUMAN CELL; INFLAMMATION; LUNG; MORPHOLOGY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PANCREAS ISLET; PRIORITY JOURNAL; REVASCULARIZATION; VASCULAR RING; ALLOTRANSPLANTATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMISTRY; CYTOLOGY; DIABETES MELLITUS, EXPERIMENTAL; DRUG COMBINATION; GENETICS; METABOLISM; PANCREAS ISLET TRANSPLANTATION; TRANSGENIC MOUSE; TRANSPLANTATION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION;

ANIMALIA; MUS;

ACTINS; ALPHA 1-ANTITRYPSIN; ANIMALS; CELLS, CULTURED; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; DRUG COMBINATIONS; EPITHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LAMININ; LUNG; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS; TRANSCRIPTOME; TRANSPLANTATION, HOMOLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VON WILLEBRAND FACTOR;

EID: 84886392378     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X657701     Document Type: Article

References (77)

1. Albini, A.; Brigati, C.; Ventura, A.; Lorusso, G.; Pinter, M.; Morini, M.; Mancino, A.; Sica, A.; Noonan, D. M. Angiostatin anti-angiogenesis requires IL-12: The innate immune system as a key target. J. Transl. Med. 7:1-8; 2009.
2. Barshes, N. R.; Wyllie, S.; Goss, J. A. Inflammationmediated dysfunction and apoptosis in pancreatic islet transplantation: Implications for intrahepatic grafts. J. Leukoc. Biol. 77(5):587-597; 2005.
3. Bell, E.; Cao, X.; Moibi, J. A.; Greene, S. R.; Young, R.; Trucco, M.; Gao, Z.; Matschinsky, F. M.; Deng, S.; Markman, J. F.; Naji, A.; Wolf, B. A. Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes 52(11):2731-2739; 2003.
4. Bellacen, K.; Lewis, E. Aortic ring assay. J. Vis. Exp. 33:1564; 2009.
5. Bosco, D.; Meda, P.; Morel, P.; Matthey-Doret, D.; Caille, D.; Toso, C.; Buhler, L. H.; Berney, T. Expression and secretion of a-1-proteinase inhibitor are regulated by proinflammatory cytokines in human pancreatic islet cells. Diabetologia 48(8):1523-1533; 2005.
6. Brissova, M.; Fowler, M.; Wiebe, P.; Shostak, A.; Shiota, M.; Radhika, A.; Lin, P. C.; Gannon, M.; Powers, A. C. Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets. Diabetes 53(5):1318-1325; 2004.
7. Brissova, M.; Shostak, A.; Shiota, M.; Wiebe, P. O.; Poffenberger, G.; Kantz, J.; Chen, Z.; Carr, C.; Jerome, W. G.; Chen, J.; Baldwin, H. S.; Nicholson, W.; Bader, D. M.; Jetton, T.; Gannon, M.; Powers, A. C. Pancreatic islet production of vascular endothelial growth factor-a is essential for islet vascularization, revascularization, and function. Diabetes 55(11):2974-2985; 2006.
8. Cabrera, O.; Berman, D. M.; Kenyon, N. S.; Ricordi, C.; Berggren, P. O.; Caicedo, A. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc. Natl. Acad. Sci. USA 103(7):2334-2339; 2006.
9. Cantaluppi, V.; Biancone, L.; Romanazzi, G. M.; Figliolini, F.; Beltramo, S.; Ninniri, M. S.; Galimi, F.; Romagnoli, R.; Franchello, A.; Salizzoni, M.; Perin, P. C.; Ricordi, C.; Segoloni, G. P.; Camussi, G. Antiangiogenic and immunomodulatory effects of rapamycin on islet endothelium: Relevance for islet transplantation. Am. J. Transplant. 6(11):2601-2611; 2006.
10. Carlsson, P. O.; Liss, P.; Andersson, A.; Jansson, L. Measurements of oxygen tension in native and transplanted rat pancreatic islets. Diabetes 47(7):1027-1032; 1998.
11. Carlsson, P. O.; Palm, F.; Mattsson, G. Low revascularization of experimentally transplanted human pancreatic islets. J. Clin. Endocrinol. Metab. 87(12):5418-5423; 2002.
12. Churg, A.; Wang, X.; Wang, R. D.; Meixner, S. C.; Pryzdial, E. L.; Wright, J. L. α-1-Antitrypsin suppresses TNF-a and MMP-12 production by cigarette smoke-stimulated macrophages. Am. J. Respir. Cell. Mol. Biol. 37(2):144-151; 2007.
13. Cross, S. E.; Richards, S. K.; Clark, A.; Benest, A. V.; Bates, D. O.; Mathieson, P. W.; Johnson, P. R.; Harper, S. J.; Smith, R. M. Vascular endothelial growth factor as a survival factor for human islets: Effect of immunosuppressive drugs. Diabetologia 50(7):1423-1432; 2007.
14. Daoud, J.; Rosenberg, L.; Tabrizian, M. Pancreatic islet culture and preservation strategies: Advances, challenges, and future outlook. Cell Transplant. 19(12):1523-1535; 2010.
15. Davidson, D. J.; Gray, M. A.; Kilanowski, F. M.; Tarran, R.; Randell, S. H.; Sheppard, D. N.; Argent, B. E.; Dorin, J. R. Murine epithelial cells: Isolation and culture. J. Cyst. Fibros. 3(Suppl 2):59-62; 2004.
16. DeLisser, H. M.; Christofidou-Solomidou, M.; Strieter, R. M.; Burdick, M. D.; Robinson, C. S.; Wexler, R. S.; Kerr, J. S.; Garlanda, C.; Merwin, J. R.; Madri, J. A.; Albelda, S. M. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am. J. Pathol. 151(3):671-677; 1997.
17. Dhami, R.; Zay, K.; Gilks, B.; Porter, S.; Wright, J. L.; Churg, A. Pulmonary epithelial expression of human α-1-Antitrypsin in transgenic mice results in delivery of α-1-Antitrypsin protein to the interstitium. J. Mol. Med. 77(4):377-385; 1999.
18. Dowd, S. K.; Rodgers, G. C.; Callen, J. P. Effective treatment with a-1-protease inhibitor of chronic cutaneous vasculitis associated with α-1-Antitrypsin deficiency. J. Am. Acad. Dermatol. 33(5 Pt 2):913-916; 1995.
19. Elias, J. A.; Kang, M. J.; Crothers, K.; Homer, R.; Lee, C. G. State of the art. Mechanistic heterogeneity in chronic obstructive pulmonary disease: Insights from transgenic mice. Proc. Am. Thorac. Soc. 3(6):494-498; 2006.
20. Elzouki, A. N.; Segelmark, M.; Wieslander, J.; Eriksson, S. Strong link between the α-1-Antitrypsin PiZ allele and Wegener's granulomatosis. J. Intern. Med. 236(5):543-548; 1994.
21. Emmerich, J. α-1-Antitrypsin and the maintenance of hemostatic balance. Haematologica 94(6):762-763; 2009.
22. Gooptu, B.; Lomas, D. A. Polymers and inflammation: Disease mechanisms of the serpinopathies. J. Exp. Med. 205(7):1529-1534; 2008.
23. Huang, H.; Campbell, S. C.; Nelius, T.; Bedford, D. F.; Veliceasa, D.; Bouck, N. P.; Volpert, O. V. α-1-Antitrypsin inhibits angiogenesis and tumor growth. Int. J. Cancer 112(6):1042-1048; 2004.
24. Ikari, Y.; Fujikawa, K.; Yee, K. O.; Schwartz, S. M. Alpha(1)-proteinase inhibitor, alpha(1)-antichymotrypsin, or alpha(2)-macroglobulin is required for vascular smooth muscle cell spreading in three-dimensional fibrin gel. J. Biol. Chem. 275(17):12799-12805; 2000.
25. Jansson, L.; Carlsson, P. O. Graft vascular function after transplantation of pancreatic islets. Diabetologia 45(6):749-763; 2002.
26. Jansson, L.; Hellerstrom, C. Stimulation by glucose of the blood flow to the pancreatic islets of the rat. Diabetologia 25(1):45-50; 1983.
27. Kasahara, Y.; Tuder, R. M.; Cool, C. D.; Lynch, D. A.; Flores, S. C.; Voelkel, N. F. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am. J. Respir. Crit. Care Med. 163(3 Pt 1):737-744; 2001.
28. Kasahara, Y.; Tuder, R. M.; Taraseviciene-Stewart, L.; Le Cras, T. D.; Abman, S.; Hirth, P. K.; Waltenberger, J.; Voelkel, N. F. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Invest. 106(11):1311-1319; 2000.
29. Kidszun, A.; Schneider, D.; Erb, D.; Hertl, G.; Schmidt, V.; Eckhard, M.; Preissner, K. T.; Breier, G.; Bretzel, R. G.; Linn, T. Isolated pancreatic islets in three-dimensional matrices are responsive to stimulators and inhibitors of angiogenesis. Cell Transplant. 15(6):489-497; 2006.
30. Koulmanda, M.; Bhasin, M.; Hoffman, L.; Fan, Z.; Qipo, A.; Shi, H.; Bonner-Weir, S.; Putheti, P.; Degauque, N.; Libermann, T. A.; Auchincloss, Jr., H.; Flier, J. S.; Strom, T. B. Curative and b-cell regenerative effects of a-1- antitrypsin treatment in autoimmune diabetic NOD mice. Proc. Natl. Acad. Sci. USA 105(42):16242-16247; 2008.
31. Kurtagic, E.; Jedrychowski, M. P.; Nugent, M. A. Neutrophil elastase cleaves VEGF to generate a VEGF fragment with altered activity. Am. J. Physiol. Lung Cell Mol. Physiol. 296(3):L534-546; 2009.
32. Langlois, A.; Bietiger, W.; Seyfritz, E.; Maillard, E.; Vivot, K.; Peronet, C.; Meyer, N.; Kessler, L.; Jeandidier, N.; Pinget, M.; Sigrist, S. Improvement of Rat islet viability during transplantation: Validation of pharmacological approach to induce VEGF overexpression. Cell Transplant. 20(9):1333-1342; 2011.
33. Lewis, E. C. Expanding the clinical indications for a-1- antitrypsin therapy. Mol. Med. 18:957-970; 2012.
34. Lewis, E. C.; Mizrahi, M.; Toledano, M.; Defelice, N.; Wright, J. L.; Churg, A.; Shapiro, L.; Dinarello, C. A. α-1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc. Natl. Acad. Sci. USA 105(42):16236-162341; 2008.
35. Lewis, E. C.; Shapiro, L.; Bowers, O. J.; Dinarello, C. A. α-1-Antitrypsin monotherapy prolongs islet allograft survival in mice. Proc. Natl. Acad. Sci. USA 102(34):12153-12158; 2005.
36. Lifson, N.; Kramlinger, K. G.; Mayrand, R. R.; Lender, E. J. Blood flow to the rabbit pancreas with special reference to the islets of Langerhans. Gastroenterology 79(3):466-473; 1980.
37. Lindstrom, F. D.; Skogh, T.; Lundstrom, I. M. Alpha(1) antitrypsin deficiency in a patient with systemic vasculitis and primary Sjogren's syndrome. Ann. Rheum. Dis. 61(10):945-946; 2002.
38. Mattsson, G.; Jansson, L.; Carlsson, P. O. Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes 51(5):1362-1366; 2002.
39. Mazodier, P.; Elzouki, A. N.; Segelmark, M.; Eriksson, S. Systemic necrotizing vasculitides in severe α-1-Antitrypsin deficiency. QJM. 89(8):599-611; 1996.
40. Miao, G.; Ostrowski, R. P.; Mace, J.; Hough, J.; Hopper, A.; Peverini, R.; Chinnock, R.; Zhang, J.; Hathout, E. Dynamic production of hypoxia-inducible factor-1a in early transplanted islets. Am. J. Transplant. 6(11):2636-2643; 2006.
41. Molnar, C.; Essand, M.; Wennberg, L.; Berne, C.; Larsson, E.; Tufveson, G.; Korsgren, O. Islet engraftment and revascularization in clinical and experimental transplantation. Cell Transplant. 22(2):243-251; 2013.
42. Mordwinkin, N. M.; Louie, S. G. Aralast: An a-1-protease inhibitor for the treatment of a-antitrypsin deficiency. Expert Opin. Pharmacother. 8(15):2609-2614; 2007.
43. Moritz, W.; Meier, F.; Stroka, D. M.; Giuliani, M.; Kugelmeier, P.; Nett, P. C.; Lehmann, R.; Candinas, D.; Gassmann, M.; Weber, M. Apoptosis in hypoxic human pancreatic islets correlates with HIF-1a expression. FASEB J. 16(7):745-747; 2002.
44. Ono, M. Molecular links between tumor angiogenesis and inflammation: Inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci. 99(8):1501-1506; 2008.
45. Orlidge, A.; D'Amore, P. A. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J. Cell Biol. 105(3):1455-1462; 1987.
46. Ozeri, E.; Mizrahi, M.; Shahaf, G.; Lewis, E. C. a-1- Antitrypsin promotes semimature, IL-10-producing and readily migrating tolerogenic dendritic cells. J. Immunol. 189(1):146-153; 2012.
47. Petrache, I.; Fijalkowska, I.; Medler, T. R.; Skirball, J.; Cruz, P.; Zhen, L.; Petrache, H. I.; Flotte, T. R.; Tuder, R. M. α-1-Antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am. J. Pathol. 169(4):1155-1166; 2006.
48. Petrache, I.; Fijalkowska, I.; Zhen, L.; Medler, T. R.; Brown, E.; Cruz, P.; Choe, K. H.; Taraseviciene-Stewart, L.; Scerbavicius, R.; Shapiro, L.; Zhang, B.; Song, S.; Hicklin, D.; Voelkel, N. F.; Flotte, T.; Tuder, R. M. A novel antiapoptotic role for α-1-Antitrypsin in the prevention of pulmonary emphysema. Am. J. Respir. Crit. Care. Med. 173(11):1222-1228; 2006.
49. Petrache, I.; Hajjar, J.; Campos, M. Safety and efficacy of α-1-Antitrypsin augmentation therapy in the treatment of patients with α-1-Antitrypsin deficiency. Biologics 3:193-204; 2009.
50. Pott, G. B.; Chan, E. D.; Dinarello, C. A.; Shapiro, L. a-1- Antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J. Leukoc. Biol. 85(5):886-895; 2009.
51. Pusztaszeri, M. P.; Seelentag, W.; Bosman, F. T. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J. Histochem. Cytochem. 54(4):385-395; 2006.
52. Rizvi, M.; Pathak, D.; Freedman, J. E.; Chakrabarti, S. CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease. Trends Mol. Med. 14(12):530-538; 2008.
53. Robertson, R. P. Islet transplantation a decade later and strategies for filling a half-full glass. Diabetes 59(6):1285-1291; 2010.
54. Roedersheimer, M.; West, J.; Huffer, W.; Harral, J.; Benedict, J. A bone-derived mixture of TGF-b-superfamily members forms a more mature vascular network than bFGF or TGF-b2 in vivo. Angiogenesis 8(4):327-338; 2005.
55. Savige, J. A.; Chang, L.; Cook, L.; Burdon, J.; Daskalakis, M.; Doery, J. α-1-Antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)- associated systemic vasculitis. Clin. Exp. Immunol. 100(2): 194-197; 1995.
56. Segelmark, M.; Elzouki, A. N.; Wieslander, J.; Eriksson, S. The PiZ gene of α-1-Antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int. 48(3):844-850; 1995.
57. Shahaf, G.; Moser, H.; Ozeri, E.; Mizrahi, M.; Abecassis, A.; Lewis, E. C. α-1-Antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection. Mol. Med. 17(9-10): 1000-1011; 2011.
58. Stendahl, J. C.; Kaufman, D. B.; Stupp, S. I. Extracellular matrix in pancreatic islets: Relevance to scaffold design and transplantation. Cell Transplant. 18(1):1-12; 2009.
59. Strom, T. B. Saving islets from allograft rejection. Proc. Natl. Acad. Sci. USA 102(36):12651-12652; 2005.
60. Takii, Y.; Inoue, H.; Karashima, E.; Akahoshi, M.; Furugo, I.; Hattori, S.; Yamanaka, M.; Kinoshita, S.; Hamasaki, N.; Shimoda, K.; Nakashima, H.; Tsukamoto, H.; Horiuchi, T.; Otsuka, T.; Harada, M. Systemic vasculitis associated with a-l-Antitrypsin deficiency. Intern. Med. 42(7):619-623; 2003.
61. Tilg, H.; Vannier, E.; Vachino, G.; Dinarello, C. A.; Mier, J. W. Anti-inflammatory properties of hepatic acute phase proteins: Preferential induction of interleukin-1 (IL-1) receptor antagonist over IL-1b synthesis by human peripheral blood mononuclear cells. J. Exp. Med. 178(5):1629-1636; 1993.
62. Tuder, R. M.; Yoshida, T.; Fijalkowka, I.; Biswal, S.; Petrache, I. Role of lung maintenance program in the heterogeneity of lung destruction in emphysema. Proc. Am. Thorac. Soc. 3(8):673-679; 2006.
63. Tuder, R. M.; Zhen, L.; Cho, C. Y.; Taraseviciene-Stewart, L.; Kasahara, Y.; Salvemini, D.; Voelkel, N. F.; Flores, S. C. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am. J. Respir. Cell. Mol. Biol. 29(1):88-97; 2003.
64. Vajkoczy, P.; Olofsson, A. M.; Lehr, H. A.; Leiderer, R.; Hammersen, F.; Arfors, K. E.; Menger, M. D. Histogenesis and ultrastructure of pancreatic islet graft microvasculature. Evidence for graft revascularization by endothelial cells of host origin. Am. J. Pathol. 146(6):1397-1405; 1995.
65. van Belle, T. L.; Coppieters, K. T.; von Herrath, M. G. Type 1 diabetes: Etiology, immunology, and therapeutic strategies. Physiology 91(1):79-118; 2011.
66. Van Molle, W.; Libert, C.; Fiers, W.; Brouckaert, P. α-1-Acid glycoprotein and α-1-Antitrypsin inhibit TNF-induced but not anti-Fas-induced apoptosis of hepatocytes in mice. J. Immunol. 159(7):3555-3564; 1997.
67. Volpert, O. V.; Stellmach, V.; Bouck, N. The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression. Breast Cancer Res. Treat. 36(2):119-126; 1995.
68. Voronov, E.; Carmi, Y.; Apte, R. N. Role of IL-1-mediated inflammation in tumor angiogenesis. Adv. Exp. Med. Biol. 601:265-270; 2007.
69. Weir, G. C.; Koulamnda, M. Control of inflammation with α-1-Antitrypsin: A potential treatment for islet transplantation and new-onset type 1 diabetes. Curr. Diab. Rep. 9(2):100-102; 2009.
70. Wenger, R. H.; Rolfs, A.; Marti, H. H.; Bauer, C.; Gassmann, M. Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line. J. Biol. Chem. 270(46): 27865-27870; 1995.
71. West, X. Z.; Malinin, N. L.; Merkulova, A. A.; Tischenko, M.; Kerr, B. A.; Borden, E. C.; Podrez, E. A.; Salomon, R. G.; Byzova, T. V. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 467(7318):972-976; 2010.
72. Wu, W. K.; Llewellyn, O. P.; Bates, D. O.; Nicholson, L. B.; Dick, A. D. IL-10 regulation of macrophage VEGF production is dependent on macrophage polarisation and hypoxia. Immunobiology 215(9-10):796-803; 2010.
73. Xie, F.; Shi, Q.; Wang, Q.; Ge, Y.; Chen, Y.; Zuo, J.; Gu, Y.; Deng, H.; Mao, H.; Hu, Z.; Zhou, Y.; Zhang, X. CD40 is a regulator for vascular endothelial growth factor in the tumor microenvironment of glioma. J. Neuroimmunol. 222(1-2):62-69; 2010.
74. Yang, P.; Wentzlaff, K. A.; Katzmann, J. A.; Marks, R. S.; Allen, M. S.; Lesnick, T. G.; Lindor, N. M.; Myers, J. L.; Wiegert, E.; Midthun, D. E.; Thibodeau, S. N.; Krowka, M. J. α-1-Antitrypsin deficiency allele carriers among lung cancer patients. Cancer Epidemiol. Biomarkers Prev. 8(5): 461-465; 1999.
75. Zelvyte, I.; Stevens, T.; Westin, U.; Janciauskiene, S. α-1-Antitrypsin and its C-terminal fragment attenuate effects of degranulated neutrophil-conditioned medium on lung cancer HCC cells, in vitro. Cancer Cell Int. 4(1):7; 2004.
76. Zhang, B.; Lu, Y.; Campbell-Thompson, M.; Spencer, T.; Wasserfall, C.; Atkinson, M.; Song, S. α-1-Antitrypsin protects β-cells from apoptosis. Diabetes 56(5):1316-1323; 2007.
77. Zhang, N.; Richter, A.; Suriawinata, J.; Harbaran, S.; Altomonte, J.; Cong, L.; Zhang, H.; Song, K.; Meseck, M.; Bromberg, J.; Dong, H. Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Diabetes 53(4):963-970; 2004.